Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Indications for Preservation, Resection and Reconstruction of the Facial Nerve in.

Slides:



Advertisements
Similar presentations
Evidence-based Public Health Interventions Robert S. Lawrence, MD Bloomberg School of Public Health Johns Hopkins University April 20, 2005.
Advertisements

Recent advances in Radiotherapy of CNS Tumours Dr Vivek Bansal Director, Dept of Radiation Oncology HCG Cancer Centre,Sola Ahmedabad,Gujarat,India .
CANCER SCREENING 2011 DELAWARE CANCER EDUCATION ALLIANCE STEPHEN S. GRUBBS, M.D. HELEN F. GRAHAM CANCER CENTER DELAWARE CANCER CONSORTIUM OCTOBER 5, 2011.
516 (32723) Phase III trial comparing AC (x4)taxane (x4) with taxane (x8) as adjuvant therapy for node-positive breast cancer: Results of N-SAS-BC02.
Post-operative Radiotherapy for Esophageal Cancer Parag Sanghvi, M.D., M.S.P.H. Department of Radiation Medicine Esophageal Care Conference 3/26/2007.
DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.
Age as a prognostic factor for head and neck squamous cell carcinoma: should older patients be treated differently? Udi Cinamon 1, Michael P. Hier 2, Martin.
Borderline Resectable Pancreatic Carcinoma
HOW EVIDENCE AND EVIDENCE-BASED CLINICAL GUIDELINES HELP CAREGIVERS SUPPORT TREATMENT "Do Carers Care About Research? Laura (Collins) Lyster-Mensh, Executive.
Martina Rastovac Mentor: A. Žmegač Horvat. Actor Patrick Swayze died after a 20-month battle with pancreatic cancer. He was 57.Patrick Swayze.
Department of Health and Human Services Measuring Clinical Lab Ordering Quality: Theory and Practice Steven M. Asch MD MPH VA, RAND, UCLA April 29, 2005.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
METHODS OF CLOSURE FOR GASTROSCHISIS AND OMPHALOCELE
Copyright restrictions may apply JAMA Facial Plastic Surgery Journal Club Slides: Reconstruction of the Lateral Mandibular Defect Shnayder Y, Lin D, Desai.
Pediatric Brain Tumors
AJCC TNM Staging 7th Edition Breast Case #3
Introduction to evidence based medicine
Enhanced recovery meta-analysis Kirsty Cattle Research Registrar.
Breast Cancer: Follow up and Management of recurrence Carol Marquez, M.D. Associate Professor Department of Radiation Medicine OHSU.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Grand Rounds Paper of the week 1. Subcuticular sutures versus staples for skin closure after open gastrointestinal surgery: a phase 3, multicentre, open-
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
SYNOPSIS OF THE PROTOCOL Title: Pregnancy Associated Breast Cancer (PABC); Prospective Data Registry in Saudi Arabia Sponsor: Oncology Department, King.
AGO-OVAR DESKTOP III (Protocol AGO - OVAR OP.4)
Objectives of Work Package 5 objectives for today Information on centres of expertise for rare cancers WP leader: Sabine Siesling.
A Phase II Study to Evaluate the Safety and Toxicity of Sparing Radiation to the Pathologic N0 Side of the Neck in Squamous Cell.
Ademola Popoola,BUHARI TAJUDEEN,Fidelis Ushie,Hamid Olanipekun. Department of Surgery University of Ilorin Teaching Hospital,Ilorin. Multiple Primary Cancers.
Incidence of Childhood Cancer. What is cancer ? Uncontrolled growth of cells Are these cancer cells abnormal? No, but their behaviour is.
INT Translational research in head and neck cancer: preoperative chemotherapy in oral cavity cancer based on disease molecular profiling. Paolo Bossi MSO.
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
A. R. Markos FRCOG FRCP Consultant in Genito Urinary Medicine and Sexual Health Mid Staffordshire NHS Foundation Trust Stafford, UK.
Postoperative Radiotherapy for Patients with Stage II or III Nonsmall Cell Lung Cancer treated with Sublobar Resections: A SEER Registry Analysis Scott.
Pathology Reports Nicole Draper, MD.
Neurology Case Conference 4 PROGNOSIS. Mortality and Morbidity Some patients die with meningioma and not from it Meningiomas usually grow slowly, and.
Evidence-Based Medicine Presentation [Insert your name here] [Insert your designation here] [Insert your institutional affiliation here] Department of.
Copyright restrictions may apply JAMA Facial Plastic Surgery Journal Club Slides: Objective Assessment of Smile Outcomes Bhama PK, Weinberg JS, Lindsay.
EVIDENCE BASED PRACTICE BY MOHEB KHOUZAM MD. EVIDENCE BASED PRACTICE  1- TYPES OF STUDY DESIGNS  2- RECOMMENDATIONS.
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC randomised trial From.
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
Evidence-Based Practice
Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma JIN Chen, YAO Lie, LONG.
Levels of Evidence Dr Chetan Khatri Steering Committee, STARSurg.
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
EVIDENCE-BASED MEDICINE AND PHARMACY 1. Evidence-based medicine 2. Evidence-based pharmacy.
How clinicians use data to make an impact on clinical outcomes Andrew Brodbelt Consultant Neurosurgeon and Clinical Director of Neurosurgery, The Walton.
NABEEL BONDAGJI, MD, FRCSC CONSULTANT PERINATOLOGIST KFSH&RC - JEDDAH “CONTRACEPTION IN WOMEN WITH MEDICAL DISORDERS”
It is essential to obtain the exact history of the hypersalivation as well as a thorough and complete past medical history. Oral evaluation should be performed,
Trans-oral microendoscopic KTP-532 Laser assisted excision of Hypopharngeal cancer - a case series Dr.Dipak Ranjan Nayak, Dr.Balakrishnan R, Dr.Suraj Nair.
Introduction to General Epidemiology (2) By: Dr. Khalid El Tohami.
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer NEJM July vol 359 R2 임규성.
Department of Clinical Radiotherapy, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK R4 한재준 1.
ORAL RECONSTRUCTION AFTER EXCISION OF SOFT TISSUE MALIGNANCIES.
Neoadjuvant chemotherapy in the treatment of NSCLC Department of Thoracic Oncology, University Hospital Ghent, Belgium Current Opinion in Oncology 2007,
Presented By Shin Fujita at 2016 ASCO Annual Meeting
Laparoscopic colorectal surgery
PANCREATODUODENECTOMY + MULTIVISCERAL RESECTION YES/NO
Developing a guideline
Non-melanoma skin cancer reconstruction of the head and neck region at Northampton General Hospital: a case series. Iqbal U1, Kapasi F2 Ameerally P3 1.
Single center experiences with intraoperative radiotherapy (IORT) as a boost during oncoplastic breast-conserving surgery Malter W¹, Puppe J¹, Rogée K¹,
SMFM Clinical Practice Guidelines
Evidence-Based Practice I: Definition – What is it?
Neuropathology Case Study
Society Perspective 07 SEPT 2018
Evidence-Based Practice
Neoadjuvant Adjuvant Curative Palliative
earching the best evidence
PERFORMING THE EMBRYO TRANSFER: A GUIDELINE
Pre-operative consideration and Selection of Microsurgical Vessels
Evidence-Based Public Health
The Development of an International Registry
Presentation transcript:

Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Indications for Preservation, Resection and Reconstruction of the Facial Nerve in Parotid Cancer Guntinas-Lichius O Department of Otorhinolaryngology Institute of Phoniatry and Pedaudiology Friedrich-Schiller-University Jena Director: O. Guntinas-Lichius

Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Background Paralysis of the face is caused in 5% of patients by a tumor invading the facial nerve. The most frequent extracranial cause is a malignant parotid tumor. The incidence of facial palsy by parotid cancer is 12-25%. Parotid cancer is a rare disease: 2% of head and neck cancer. Hence: Less than 0.5% of head neck cancer patients have parotid cancer with facial palsy. Hence: EBM studies are rare and difficult to perform.

Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Preservation of the Facial Nerve in Parotid Cancer is possible, if … the patient with primary parotid cancer presents with normal facial nerve function (as >75% of patients do). an operation microscope is used. in cases of uncertainty: Electromyography shows no signs of nerve degeneration. there is no intraoperative microscopic suspicion of tumour infiltration of the nerve. EBM Level III

Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Preservation of the Facial Nerve in Parotid Cancer … results often (~50%) in a transient facial paresis, but seldom (~3%) the patients develop a permanent paresis. in patients with normal facial function does not lead to inferior disease-free and overall survival than it would be after resection of the intact nerve. EBM Level II-3/III

Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Resection of the Facial Nerve in Parotid Cancer is necessary if the nerve is infiltrated. Criteria: clinical palsy, electrical palsy, signs of infiltration, frozen section. Only the parts of the nerve are resected that are infiltrated. Because: Negative margins are very important for disease-free survival. And from the oncological point of view facial nerve infiltration is not different from any other tumor infiltration site. EBM Level II-1/II-3

Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Reconstruction of the Facial Nerve in Parotid Cancer should be performed as fast as possible, i.e., at best in one-step procedure with cancer surgery gives best functional results (better than muscle/sling plasty). Primary repair is better than secondary reconstruction. Postoperative radiotherapy seems not to have a harmful effect on facial function. The defect often concerns the facial nerve fan. This could be repaired optimally by interposition grafts, hypoglossal- facial nerve jump anastomosis or a combined approach. EBM Level II-3/III

Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 If only secondary reconstruction is possible … Because the patients fails the selections criteria for primary repair: extension of the nerve defect, localization, prognosis, age, general health status, wishes, status of the mimic muscles, it should be noted: The optimal time window for direct facial nerve suture or nerve grafting closes after 6 months. In such situation, up to 2 years after injury, a hypoglossal- facial nerve jump anastomosis should be considered. EBM Level II-3/III

Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 If a nerve reconstruction is not possible … Masseter m. transposition is second choice. Is recommended in combination with nerve reconstruction. Static suspension is third choice. Autogenic and not alloplastic material is recommended: fascia lata and palmaris longus tendon. Free microvascular muscle transfer is typically not indicated in parotid cancer patients. Upper lid loading is a reliable method for eye reanimation. Temporalis muscle transposition is the best choice for reconstruction of the corner of the mouth because of its length and vector. EBM Level II-3/III

Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008

Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Empfehlung D: Level 1: Es gibt ausreichende Nachweise für die Wirksamkeit aus systematischen Überblicksarbeiten (Meta-Analysen) über zahlreiche randomisiert-kontrollierte Studien. Level 2: Es gibt Nachweise für die Wirksamkeit aus zumindest einer randomisierten, kontrollierten Studie. Level 3: Es gibt Nachweise für die Wirksamkeit aus methodisch gut konzipierten Studien, ohne randomisierte Gruppenzuweisung. Level 4a: Es gibt Nachweis für die Wirksamkeit aus klinischen Berichten. Level 4b: Stellt die Meinung respektierter Experten dar, basierend auf klinischen Erfahrungswerten bzw. Berichten von Experten-Komitees. Recommendation USA Level I: Evidence obtained from at least one properly designed randomized controlled trial.randomized controlled trial Level II-1: Evidence obtained from well-designed controlled trials without randomization.randomization Level II-2: Evidence obtained from well-designed cohort or case-control analytic studies, preferably from more than one center or research group.cohortcase-control Level II-3: Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled trials might also be regarded as this type of evidence. Level III: Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees Anmerkungen - werden nicht im Vortrag gezeigt